Effects of Orally Delivered Alpha-Galactosidase A on Gastrointestinal Symptoms in Patients With Fabry Disease

Gastroenterology. 2020 Oct;159(4):1602-1604. doi: 10.1053/j.gastro.2020.06.007. Epub 2020 Jun 12.

¹ Department of Internal Medicine D, and Interdisciplinary Fabry Center (IFAZ), University Hospital Muenster, Muenster, Germany.
² Department of Pediatrics, Division of Medical Genetics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
³ Department of Internal Medicine D, and Interdisciplinary Fabry Center (IFAZ), University Hospital Muenster, Muenster, Germany. Electronic address: Eva.Brand@ukmuenster.de.

No abstract available

MeSH terms